FROM YAHOO NEWS
Latest news, live updates on 2024 election results
NasdaqCM - Delayed Quote USD
Hoth Therapeutics, Inc. (HOTH)
At close: November 5 at 4:00 PM EST
After hours: November 5 at 4:17 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.34 | -0.32 | -1.32 | -0.71 |
| Low Estimate | -0.37 | -0.36 | -1.39 | -0.87 |
| High Estimate | -0.3 | -0.26 | -1.18 | -0.58 |
| Year Ago EPS | -0.6 | -0.32 | -2.3 | -1.32 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.72 | -0.51 | -0.43 | -0.43 |
| EPS Actual | -0.6 | -0.32 | -0.46 | -0.24 |
| Difference | 0.12 | 0.19 | -0.03 | 0.19 |
| Surprise % | 16.70% | 37.30% | -7.00% | 44.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.34 | -0.32 | -1.32 | -0.71 |
| 7 Days Ago | -0.34 | -0.32 | -1.32 | -0.71 |
| 30 Days Ago | -0.32 | -0.3 | -1.28 | -0.72 |
| 60 Days Ago | -0.32 | -0.3 | -1.28 | -0.72 |
| 90 Days Ago | -0.43 | -0.37 | -1.65 | -0.86 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HOTH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 43.30% | -- | -- | 5.40% |
| Next Qtr. | 0.00% | -- | -- | 11.80% |
| Current Year | 42.60% | -- | -- | 2.20% |
| Next Year | 46.20% | -- | -- | 12.50% |
| Next 5 Years (per annum) | -- | -- | -- | 11.03% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/5/2024 |
| Maintains | EF Hutton: Buy to Buy | 4/2/2024 |
Related Tickers
LIXT Lixte Biotechnology Holdings, Inc.
1.8900
-3.08%
GRI GRI Bio, Inc.
0.9900
-4.81%
ADTX Aditxt, Inc.
0.4736
-3.35%
APVO Aptevo Therapeutics Inc.
0.2680
-4.96%
AVTE Aerovate Therapeutics, Inc.
2.7000
-0.74%
TOVX Theriva Biologics, Inc.
1.9700
-4.83%
BNOX Bionomics Limited
0.4930
+156.77%
NBY NovaBay Pharmaceuticals, Inc.
0.7550
-0.13%
NLSP NLS Pharmaceutics AG
4.0400
-7.97%
PLRZ Polyrizon Ltd.
1.0600
+1.92%